Government Medical Utilities Vaccination 
FDA Law Blog
JUNE 2, 2023
Kirschenbaum — Last Friday, May 26, CMS published in the Federal Register an assortment of proposals to change the regulations governing the Medicaid Drug Rebate Program. The preamble notes that this information would help ensure that drugs are being used for approved or otherwise medically accepted indications.
FDA Law Blog
AUGUST 14, 2022
Starting July 1, 2023, the IRA will also limit to $35 the total monthly contribution by a Medicare Part B beneficiary for insulin purchased through a durable medical equipment (“DME”) supplier. In return for providing the MFP, manufacturers of selected drugs do receive coverage, but high utilization drugs are certain to have coverage anyway.
Doctors for America
APRIL 29, 2025
We hope that Commissioner Makary will utilize his experience to help ensure FDA puts patients over politics throughout his tenure. Both Secretary Kennedy and Commissioner Makary have proposed strategies to mitigate the “revolving door” between the government and the industries they regulate.
Expert insights. Personalized for you.
59 
Let's personalize your content